Ticker Launch
Sign inTry it free

SPAC · Merger completed

Semper Paratus Acquisition Corp

Business combination with Tevogen Bio Inc

Semper Paratus Acquisition Corp is a blank-check company (SPAC) that raised $300M in its initial public offering on Nov 5, 2021, listing on Nasdaq Global Market. It completed its business combination with Tevogen Bio Inc on Feb 14, 2024; the combined company is Tevogen Bio Holdings Inc. (TVGN). Cantor led the IPO. Reed Smith advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.

Tevogen Bio Inc is developing a precision T cell platform designed to eliminate malignant and virally infected cells while leaving healthy cells intact. Its goal is personalized immunotherapies for large patient populations affected by common cancers and viral infections.

Status
Merger completed
IPO date
Nov 5, 2021
IPO size
$300M
IPO exchange
Nasdaq Global Market
Target
Tevogen Bio Inc
Announced
Jun 29, 2023
Closed
Feb 14, 2024
Combined company
Tevogen Bio Holdings Inc. (TVGN)
IPO underwriters
Cantor
SPAC counsel (IPO)
Reed Smith and Maples and Calder
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2024